ArticleCirculation reports2026
Impact of Zinc Deficiency in Heart Failure Patients According to Ejection Fraction Subtype - An Observational Study.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Zinc deficiency is frequent in heart failure (HF) and may worsen prognosis. Methods and Results: We retrospectively analyzed 157 HF patients hospitalized between 2016 and 2019. Zn deficiency was defined as ≤60 µg/dL. Correlations between Zn and clinical indices were examined, and 1-year outcomes were evaluated. Zn deficiency correlated with anemia, malnutrition, and reduced muscle indices but not with dietary intake. Zn-deficient patients had higher rates of mortality/readmission (43% vs. 25%, P=0.027), especially in HF with preserved ejection fraction (HFpEF: 62% vs. 26%, P=0.01). Conclusions: Zn deficiency predicted poor prognosis in HF, particularly HFpEF, and may serve as a simple biomarker for risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.